by: Alex Brown, Inside INdiana Business
Posted: Apr 20, 2021 / 4:24 PM EST / Updated: April 20, 2021 / 4:24 PM EST
WARSAW, IND. (Inside INdiana Business) – Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has received approval from the US Food and Drug Administration for its ROSA Partial Knee System. The medical device maker says the system will be used for robotic partial knee replacement surgery.
The system is part of Zimmer Biomet’s ROSA Robotics platform, which also includes devices for knee endoprostheses, neurosurgery and spinal surgery.
“The FDA approval of the ROSA Partial Knee System just two years after the introduction of the ROSA Total Knee System builds on the success of our ROSA Robotics portfolio, which aims to improve surgical accuracy, precision and efficiency through intraoperative interventions each process can be personalized, ”said Ivan Tornos, Zimmer Biomet’s chief operating officer, in a press release. “As a result, the ROSA Partial Knee System enables patients to really get the knee that best suits their needs.”
Zimmer Biomet said the system uses proprietary imaging technology and real-time intraoperative data acquisition of a patient’s soft tissue and bone anatomy to improve flexion and restoration of natural joint motion in the knee.